Literature DB >> 19957115

The proliferation marker thymidine kinase 1 level is high in normal kidney tubule cells compared to other normal and malignant renal cells.

Pengcheng Luo1, Naining Wang, Ellen He, Staffan Eriksson, Ji Zhou, Guozhu Hu, Jie Zhang, Sven Skog.   

Abstract

The activity of the proliferation related enzyme thymidine kinase 1 (TK1) was reported to be 3-fold higher in extracts from normal kidney tissue as compare to renal carcinoma extracts [3]. To verify these unexpected results, determinations of the protein levels of TK1 in normal kidney and in samples from different types of renal cell carcinoma (RCC) were done with immunohistochemistry and Western blot analysis. Two anti-TK1 peptide antibodies reacting with different TK1 epitops were used. TK1 levels were high in tubule cells as compared to glomerulus cells and connective tissue cells, while an intermediary TK1 was observed in renal cell carcinoma (RCC) cells. Western blot analysis demonstrated high levels of TK1 in extract from normal kidney, and lower levels of TK1 in the RCC extracts. The specificity of TK1 staining was demonstrated in competition experiments with excess TK1 antigen. The high TK1 levels in normal kidney tubule cells suggest that they are in a form of activated G1-state. The relatively low TK1 level in RCC, representing TK1 expression in S-phase cells, is in accordance with the low overall proliferation rate of these tumors. These results suggest that cell cycle regulation of TK1 in normal tubule cells differ from that in other type of normal and malignant renal cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19957115     DOI: 10.1007/s12253-009-9222-5

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  20 in total

1.  Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients.

Authors:  K L O'Neill; F Zhang; H Li; D G Fuja; B K Murray
Journal:  Leukemia       Date:  2007-01-25       Impact factor: 11.528

2.  Proximal tubular epithelial cells are generated by division of differentiated cells in the healthy kidney.

Authors:  Alexander Vogetseder; Thomas Palan; Desa Bacic; Brigitte Kaissling; Michel Le Hir
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-20       Impact factor: 4.249

3.  Significance of thymidylate synthase activity in renal cell carcinoma.

Authors:  Yoichi Mizutani; Hiromi Wada; Osamu Yoshida; Masakazu Fukushima; Mitsuo Nonomura; Masahiro Nakao; Tsuneharu Miki
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

4.  Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability.

Authors:  Po-Yuan Ke; Yuan-Yeh Kuo; Chuan-Mei Hu; Zee-Fen Chang
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

5.  Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.

Authors:  Y Törnevik; B Ullman; J Balzarini; B Wahren; S Eriksson
Journal:  Biochem Pharmacol       Date:  1995-03-15       Impact factor: 5.858

6.  Cytosolic thymidine kinase is a specific histopathologic tumour marker for breast carcinomas.

Authors:  Qimin He; Yongrong Mao; Jainping Wu; Catrine Decker; Malik Merza; Naining Wang; Staffan Eriksson; Juan Castro; Sven Skog
Journal:  Int J Oncol       Date:  2004-10       Impact factor: 5.650

7.  Significance of thymidine kinase activity in renal cell carcinoma.

Authors:  Yoichi Mizutani; Hiromi Wada; Osamu Yoshida; Masakazu Fukushima; Masahiro Nakao; Tsuneharu Miki
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

8.  Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-CDH1-mediated pathway.

Authors:  Po-Yuan Ke; Zee-Fen Chang
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

9.  Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer.

Authors:  Seiichiro Ozono; Noriomi Miyao; Tatsuo Igarashi; Ken Marumo; Hayakazu Nakazawa; Momokuni Fukuda; Tomoyasu Tsushima; Noriaki Tokuda; Juichi Kawamura; Masaru Murai
Journal:  Jpn J Clin Oncol       Date:  2004-02       Impact factor: 3.019

10.  Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan assays.

Authors:  Fabio Gasparri; Naining Wang; Sven Skog; Arturo Galvani; Staffan Eriksson
Journal:  Eur J Cell Biol       Date:  2009-09-02       Impact factor: 4.492

View more
  2 in total

Review 1.  The proliferation marker thymidine kinase 1 in clinical use.

Authors:  Ji Zhou; Ellen He; Sven Skog
Journal:  Mol Clin Oncol       Date:  2012-09-04

2.  Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay.

Authors:  Zhi Heng Chen; Shou Qing Huang; Yande Wang; Ai Zhen Yang; Jian Wen; Xiao Hong Xu; Yan Chen; Qu Bo Chen; Ying Hong Wang; Ellen He; Ji Zhou; Sven Skog
Journal:  Sensors (Basel)       Date:  2011-11-28       Impact factor: 3.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.